The Council voted that Intestinal Antiseptic W-A be refused recognition, and that the publication of the following report be authorized.
W. A. Puckner, Secretary.
The Abbott Alkaloidal Company advertises “Intestinal Antiseptic W-A” as
“... A scientifically blended and physiologically adjusted mixture, of the pure sulphocarbolates of calcium, sodium and zinc, grs. 5, with bismuth subsalicylate, gr. 1-4 and aromatics.”
This formula is in conflict with Rule 1 in that it does not state in what proportion the sulphocarbolates are present.
The name “Intestinal Antiseptic W-A” is in conflict with Rules 4 and 8, since it is therapeutically suggestive.
The preparation is in conflict with Rules 6 and 10, in that exaggerated claims are made for it, no evidence being submitted to prove the superior value of the mixture.
The most serious of these conflicts consists in the exaggerated and misleading therapeutic claims. The advertisements say:
“This combination has no equal as an antiseptic and inhibitive agent in typhoid fever, diarrhea, dysentery,” etc.